Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

An entire exon 3 germ-line rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predisposition

  • Danièle Muller1Email author,
  • Etienne Rouleau2,
  • Inès Schultz1,
  • Sandrine Caputo2,
  • Cédrick Lefol2,
  • Ivan Bièche2,
  • Olivier Caron3,
  • Catherine Noguès4,
  • Jean Marc Limacher3,
  • Liliane Demange4,
  • Rosette Lidereau2,
  • Jean Pierre Fricker1 and
  • Joseph Abecassis1
Contributed equally
BMC Medical Genetics201112:121

DOI: 10.1186/1471-2350-12-121

Received: 14 April 2011

Accepted: 22 September 2011

Published: 22 September 2011

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
14 Apr 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
17 May 2011 Reviewed Reviewer Report - Alessandra Viel
26 May 2011 Reviewed Reviewer Report - Trinidad Caldes
30 Jun 2011 Author responded Author comments - Daniele MULLER
Resubmission - Version 3
30 Jun 2011 Submitted Manuscript version 3
22 Jul 2011 Author responded Author comments - Daniele MULLER
Resubmission - Version 4
22 Jul 2011 Submitted Manuscript version 4
15 Sep 2011 Author responded Author comments - Daniele MULLER
Resubmission - Version 5
15 Sep 2011 Submitted Manuscript version 5
Publishing
22 Sep 2011 Editorially accepted
22 Sep 2011 Article published 10.1186/1471-2350-12-121

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Division of oncogenetic, Department of Biology and Pathology, Regional Cancer Centre Paul Strauss
(2)
Oncogenetic laboratory, Institut Curie-Hospital René Huguenin
(3)
Department of oncology, Hôpitaux Universitaires de Strasbourg
(4)
Clinical oncogenetic department, Institut Curie-Hospital René Huguenin

Advertisement